Clinical trial
Randomized, Controlled Clinical Trial for Measles - Rubella Combined Vaccine (MRVAC) Produced by POLYVAC by Technology Transfer From Japan (Phase III)
NCT03713359 is registered in ClinicalTrials.gov with Center for Research and Production of Vaccines and Biologicals, Vietnam as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Controlled Clinical Trial for Measles - Rubella Combined Vaccine (MRVAC) Produced by POLYVAC by Technology Transfer From Japan (Phase III)
- Lead sponsor
- Center for Research and Production of Vaccines and Biologicals, Vietnam
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- November 30, 2016
- Enrollment
- 756 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.